Cargando…
Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis: A Randomized Clinical Trial
IMPORTANCE: Patients with pruritus receiving hemodialysis frequently experience oppressive physical and psychiatric symptoms that directly affect their quality of life and increase mortality. However, treatment options are limited. OBJECTIVE: To determine the clinically recommended dose of difelikef...
Autores principales: | Narita, Ichiei, Tsubakihara, Yoshiharu, Uchiyama, Takuma, Okamura, Shota, Oya, Nobuyo, Takahashi, Naoki, Gejyo, Fumitake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073569/ https://www.ncbi.nlm.nih.gov/pubmed/35511180 http://dx.doi.org/10.1001/jamanetworkopen.2022.10339 |
Ejemplares similares
-
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients
por: Fishbane, Steven, et al.
Publicado: (2020) -
Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study
por: Weiner, Daniel E., et al.
Publicado: (2022) -
Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies
por: Topf, Joel, et al.
Publicado: (2022) -
Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program
por: Fishbane, Steven, et al.
Publicado: (2022) -
Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review
por: Wala, Kamila, et al.
Publicado: (2022)